This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Biotech Stocks Under $10 Blasting Higher


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

GTX (GTXI) is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions. This stock is trading up 4.9% at $3.61 in recent trading.

Today's Range: $3.44-$3.66

52-Week Range: $2.34-$6.55

Volume: 73,000

Three-Month Average Volume: 141,756

>>22 Biopharma Stocks With Breakout Potential in 2012

From a technical perspective, GTXI is jumping higher here back above its 200-day moving average of $3.56 with light volume. This move is quickly pushing GTXI within range of triggering a major breakout trade. That trade will trigger once GTXI takes out some near-term overhead resistance levels at $3.83 to $3.92, and then over some past resistance at $4.07 with high volume.

Traders should now look for long-biased trades in GTXI if it can sustain a move or close above those levels with volume that's near or above 141,756 shares. Traders could also look for long-biased trades in GTXI as long as it's trending above some near-term support at $3.30 a share, and simply anticipate that breakout. If that breakout triggers soon, then GTXI could be well on its way towards filling some of its previous gap down from February that started at around $5.75.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ARNA $1.58 0.00%
CYTX $0.24 0.00%
FOLD $6.81 0.00%
GTXI $0.72 0.00%
SNSS $0.49 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs